Claire Poll
Directeur/Membre du Conseil chez Landgate
Fortune : 4 M $ au 31/05/2024
Provenance du réseau au premier degré de Claire Poll
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 38 | |
Public Company | Chemicals: Specialty | 17 | |
Landgate
1
| Government | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Claire Poll via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ALGORAE PHARMACEUTICALS LIMITED | Pharmaceuticals: Other | Corporate Secretary | |
Bayer Pharmaceuticals Corp. | Director of Finance/CFO Chief Tech/Sci/R&D Officer | ||
Razor Risk Technologies Ltd.
Razor Risk Technologies Ltd. Information Technology ServicesTechnology Services Razor Risk Technologies Ltd. provides risk management technology and consulting solutions. It supports credit risk, market risk, clearing risk and liquidity risk in a single system, and helps to transform the way banks, hedge funds, brokers, central clearing counterparties and stock exchanges. The firm provides near real-time and pre-deal calculations that enable management to view their total exposure to individual entities on one consolidated platform. The company was founded on July 28, 1999 and is headquartered at Sydney, Australia. | Information Technology Services | Director/Board Member | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
DIVERGER LIMITED | Investment Managers | Corporate Secretary Corporate Secretary | |
RICHFIELD INTERNATIONAL LIMITED | Marine Shipping | Corporate Secretary | |
SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Investor Relations Contact Corporate Officer/Principal | |
FUTURE GENERATION AUSTRALIA LIMITED | Investment Trusts/Mutual Funds | Corporate Secretary | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TASFOODS LIMITED | Agricultural Commodities/Milling | Corporate Secretary | |
ASPEN GROUP | Real Estate Investment Trusts | Corporate Secretary Corporate Secretary | |
Victoria University | College/University | Undergraduate Degree | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
ReNeuron Ltd.
ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
ASK FUNDING LTD | Finance/Rental/Leasing | Corporate Secretary | |
STAUDE CAPITAL GLOBAL VALUE FUND LIMITED | Investment Trusts/Mutual Funds | Corporate Secretary | |
AMA GROUP LIMITED | Automotive Aftermarket | Director/Board Member Corporate Secretary | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
King's College London | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Chinova Resources Pty Ltd.
Chinova Resources Pty Ltd. Other Metals/MineralsNon-Energy Minerals Chinova Resources Pty Ltd. explores and develops copper, gold and zinc. The firm has identified targets throughout the Cloncurry tenements with prospect metals including copper, gold, molybdenum, rhenium, lead, zinc, silver, cobalt and uranium. The company was founded on January 20, 2004 and is headquartered in Milton, Australia. | Other Metals/Minerals | Corporate Secretary | |
Mertons Corporate Services Pty Ltd.
Mertons Corporate Services Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Mertons Corporate Services Pty Ltd. engages in the provision of corporate governance consultancy services. The company was founded by Mark Andrew Licciardo on November 20, 2007 and is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Founder Corporate Secretary | |
PALA PHAR | Pharmaceuticals: Major | Chairman Corporate Secretary | |
ICAR ASIA | Internet Software/Services | Director/Board Member Corporate Secretary | |
SANDON CAPITAL INVESTMENTS LIMITED | Investment Trusts/Mutual Funds | Corporate Secretary | |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
FUTURE GENERATION GLOBAL LIMITED | Investment Trusts/Mutual Funds | Corporate Secretary | |
ADHERIUM LIMITED | Medical Specialties | Corporate Secretary | |
BABY BUNTING GROUP LIMITED | Apparel/Footwear Retail | Corporate Secretary | |
DELAWARE THIRTEEN LTD | Packaged Software | Director/Board Member Corporate Secretary | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer General Counsel Human Resources Officer Chief Tech/Sci/R&D Officer | |
University of North Carolina at Chapel Hill | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Reset Pharmaceuticals, Inc.
Reset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reset Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing novel treatments for patients suffering from mental illness related to life-altering diseases. Reset Pharmaceuticals is based in Great Neck, NY and was founded by Philip Taub and Jan-Anders Karlsson. The company's lead product candidate, the oral psilocybin, is being developed to treat demoralization syndrome in patients with cancer. Reset Pharma has a highly experienced team with a strong track record of successful development, approvals, and launches of neuroscience drugs. The company also has a scientific advisory board of key opinion leaders in psychiatry, oncology, and psychedelics, as well as a strategic advisory board of business leaders and financial experts. | Pharmaceuticals: Major | Founder Director/Board Member | |
Ascension Healthcare Plc
Ascension Healthcare Plc Pharmaceuticals: MajorHealth Technology Ascension Healthcare Plc manufactures pharmaceutical products. The company was founded on September 25, 2013 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
FRONTIER DIGITAL VENTURES LIMITED | Internet Software/Services | Director/Board Member Corporate Secretary | |
VULCAN ENERGY RESOURCES LIMITED | Other Metals/Minerals | Director/Board Member Director/Board Member | |
KUNIKO LIMITED | Other Metals/Minerals | Chairman Director/Board Member | |
KOGAN.COM LTD | Internet Retail | Corporate Secretary |
Statistiques
Internationale
Australie | 27 |
Royaume-Uni | 12 |
Etats-Unis | 8 |
Allemagne | 3 |
Malaisie | 3 |
Sectorielle
Health Technology | 15 |
Finance | 8 |
Consumer Services | 7 |
Miscellaneous | 6 |
Technology Services | 5 |
Opérationnelle
Director/Board Member | 274 |
Corporate Secretary | 104 |
Corporate Officer/Principal | 93 |
Independent Dir/Board Member | 69 |
Chairman | 56 |
Relations les plus connectées
Insiders | |
---|---|
Mark Licciardo | 95 |
Martin Edwards | 38 |
Trevor Jones | 36 |
Mahendra Shah | 34 |
Rishi Gupta | 29 |
David Ebsworth | 26 |
Simon Moore | 23 |
Susan Thomas | 22 |
Belinda Cleminson | 19 |
Sven Anders Ullman | 19 |
Piers John Morgan | 18 |
Ken Cunningham Cunningham | 17 |
Gavin Rezos | 16 |
Rosheen Garnon | 15 |
Christina Ackermann | 15 |
- Bourse
- Insiders
- Claire Poll
- Connexions Sociétés